<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01073098</url>
  </required_header>
  <id_info>
    <org_study_id>2009-A01187-50</org_study_id>
    <nct_id>NCT01073098</nct_id>
  </id_info>
  <brief_title>Evaluation of Muscle StO2 as a Prognostic Factor After Out of Hospital Cardiac Arrest</brief_title>
  <official_title>Evaluation of Muscle StO2 as a Prognostic Factor After Out of Hospital Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Department of Clinical Research and Innovation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Out of hospital cardiac arrest is a major health problem. Prognosis is still poor even after
      return to spontaneous circulation. The pathophysiology of cardiac arrest implies
      ischemia-reperfusion and sepsis like syndrome. These phenomenons can lead to microvascular
      dysfunction explaining probably multi-organ failure after cardiac arrest. Few means allow the
      exploration of microvascular function in human. Muscle StO2 is a technique allowing the
      assessment of microvascular function non-invasively. The aim of this study is to evaluate
      muscle StO2 as a prognostic factor after out of hospital cardiac arrest.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Out of hospital cardiac arrest is a major health problem accounting for 375000 deaths each
      year in Europe. Even after return to spontaneous circulation, survival is poor because of
      complications such as post-anoxic encephalopathy and multi-organ failure. The pathophysiology
      of cardiac arrest implies ischemia-reperfusion and sepsis like syndrome. These conditions are
      frequently associated with microvascular dysfunction that can be the &quot;motor&quot; of multi-organ
      failure. Few means allow the exploration of microvascular function in human. Recently, StO2,
      a non-invasive technique assessing microvascular function has been described. This technique
      measures the tissular saturation of a muscle using the near-infrared spectroscopy technique.
      It has been described to be a good prognostic factor during haemorrhagic shock state. Dynamic
      parameters such as reperfusion slope allow discriminating between survivors and survivors
      after severe sepsis. This dynamic test assesses the microvasculature recruitment that could
      be a marker of better prognosis. The aim of this study is to evaluate muscle StO2 as a
      prognostic factor after out of hospital cardiac arrest.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reperfusion slope after vascular occlusion test. This parameter will be compared between survivors and non-survivors</measure>
    <time_frame>Four measurements : on admission, since the body core temperature reaches 34°, after 24 hours of hypothermia and 48 hours after admission to ICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle StO2 during the first 2 days Lactatemia during the first 2 days These parameters will be compared between survivors and non-survivors</measure>
    <time_frame>Muscle StO2 will be monitored continuously during the first 2 days Lactatemia will be measured every 12 hours until normalization</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Cardiac Arrest</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vascular occlusion test</intervention_name>
    <description>Reperfusion slope after vascular occlusion test</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Out of hospital cardiac arrest

          -  Patient aged between 18 and 80 years

          -  Having a Social Security System

        Exclusion Criteria:

          -  Pregnant women, lack of appropriate consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Christophe ORBAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Christophe ORBAN, MD</last_name>
    <phone>+33 4 92 03 33 00</phone>
    <email>orban.j@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carole ICHAI, MD, PhD</last_name>
    <phone>+33 4 92 03 33 00</phone>
    <email>ichai.c@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nice -Hôpital l'Archet</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe ORBAN, MD</last_name>
      <phone>00 33 4 92 03 33 00</phone>
      <email>orban.j@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé Hyvernat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ludovic Grech, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Dellamonica, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nice Hôpital Saint Roch</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe ORBAN, MD</last_name>
      <phone>+33 4 92 03 33 00</phone>
      <email>orban.j@chu-nice.fr</email>
    </contact>
    <contact_backup>
      <last_name>Audrey RENARD, MD</last_name>
      <phone>+33 4 92 03 33 00</phone>
      <email>audrey.27.03@free.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Christophe ORBAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole ICHAI, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hervé QUINTARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2010</study_first_submitted>
  <study_first_submitted_qc>February 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2010</study_first_posted>
  <last_update_submitted>March 23, 2012</last_update_submitted>
  <last_update_submitted_qc>March 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Nice</investigator_affiliation>
    <investigator_full_name>Department of Clinical Research and Innovation</investigator_full_name>
    <investigator_title>Department of Clinical Research and innovation (drc)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

